Through June 2027, McKesson Corporation and CVS Health will continue to work together to supply medications to retail pharmacies, mail-order and specialty pharmacies, and distribution centres. This was announced today by McKesson Corporation.
“We are pleased to continue our long-standing relationship with CVS Health and value the shared commitment of improving health outcomes for all patients”, “We are privileged to extend our partnership of more than 20 years to continue developing value propositions for patients utilizing our diverse set of differentiated assets and capabilities.”
Brian Tyler, chief executive officer, McKesson
Additionally, on Tuesday, November 1, 2022, after market close, McKesson announce its financial results for the second quarter of fiscal 2023. At 4:30 PM Eastern Time, the company will offer a live webcast of its earnings conference call for investors to discuss its financial performance.
